Patents by Inventor Mohammad Hossein Pourgholami

Mohammad Hossein Pourgholami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for the treatment of mTOR pathway related diseases
    Patent number: 10053422
    Abstract: The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoacetonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: August 21, 2018
    Assignee: Pitney Pharmaceuticals Pty Limited
    Inventors: Mohammad Hossein Pourgholami, David L. Morris, Roger Aston
  • COMPOUNDS FOR THE TREATMENT OF MTOR PATHWAY RELATED DISEASES
    Publication number: 20170369435
    Abstract: The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoacetonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
    Type: Application
    Filed: June 5, 2017
    Publication date: December 28, 2017
    Inventors: Mohammad Hossein Pourgholami, David L. Morris, Roger Aston
  • Pharmaceutical combinations for the treatment of cancer
    Patent number: 9833431
    Abstract: The present invention relates to pharmaceutical combinations comprising aminoacetonitrile derivatives and anticancer compounds. Further, the present invention relates to these pharmaceutical combinations for use in the treatment of cancer.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: December 5, 2017
    Assignee: Pitney Pharmaceuticals Pty Limited
    Inventors: David Lawson Morris, Mohammad Hossein Pourgholami, Roger Aston
  • Compounds for the treatment of mTOR pathway related diseases
    Patent number: 9790176
    Abstract: The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: October 17, 2017
    Assignee: Pitney Pharmaceuticals Pty Limited
    Inventors: Mohammad Hossein Pourgholami, David L. Morris, Roger Aston
  • PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20160228399
    Abstract: The present invention relates to pharmaceutical combinations comprising aminoacetonitrile derivatives and anticancer compounds. Further, the present invention relates to these pharmaceutical combinations for use in the treatment of cancer.
    Type: Application
    Filed: October 31, 2014
    Publication date: August 11, 2016
    Inventors: David Lawson Morris, Mohammad Hossein Pourgholami, Roger Aston
  • COMPOUNDS FOR THE TREATMENT OF MTOR PATHWAY RELATED DISEASES
    Publication number: 20150166477
    Abstract: The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
    Type: Application
    Filed: August 5, 2013
    Publication date: June 18, 2015
    Inventors: Mohammad Hossein Pourgholami, David L. Morris, Roger Aston
  • Treatment for cancer
    Patent number: 8835478
    Abstract: The present invention provides methods for the treatment of tumors, comprising administration of an effective amount of at least one taxoid and an effective amount of at least one benzimidazol carbamate compound of formula (I). The invention also provides a method for the treatment of tumors insensitive to one or more anti-mitotic drugs, the method comprising administering a effective amount of at least one benzimidazole carbamate compound of formula (I). Also provide are compositions for carrying out methods of the invention.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: September 16, 2014
    Assignee: Pitney Pharmaceuticals PTY Limited
    Inventors: David L. Morris, Mohammad Hossein Pourgholami
  • TREATMENT FOR CANCER
    Publication number: 20120214856
    Abstract: The present invention provides methods for the treatment of tumors, comprising administration of an effective amount of at least one taxoid and an effective amount of at least one benzimidazol carbamate compound of formula (I). The invention also provides a method for the treatment of tumors insensitive to one or more anti-mitotic drugs, the method comprising administering a effective amount of at least one benzimidazole carbamate compound of formula (I). Also provide are compositions for carrying out methods of the invention.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 23, 2012
    Applicant: NEWSOUTH INNOVATIONS PTY LIMITED
    Inventors: David L. Morris, Mohammad Hossein Pourgholami
  • TREATMENT FOR CANCER
    Publication number: 20090286838
    Abstract: The present invention provides methods for the treatment of tumors, comprising administration of an effective amount of at least one taxoid and an effective amount of at least one benzimidazol carbamate compound of formula (I). The invention also provides a method for the treatment of tumors insensitive to one or more anti-mitotic drugs, the method comprising administering an effective amount of at least one benzimidazole carbamate compound of formula (I). Also provide are compositions for carrying out methods of the invention.
    Type: Application
    Filed: December 6, 2005
    Publication date: November 19, 2009
    Applicant: NewSouth Innovations Pty Limited
    Inventors: David L. Morris, Mohammad Hossein Pourgholami
  • Method and composition for treatment of cancer
    Publication number: 20040067952
    Abstract: The present invention provides a method of treatment of tumours. The method comprises regional delivery to the site of the tumour a composition comprising a therapeutically effective amount of a riminophenazine compound. The present invention also provides composition comprising riminophenazine compounds in combination with lipids.
    Type: Application
    Filed: August 8, 2003
    Publication date: April 8, 2004
    Inventors: David Lawson Morris, Mohammad Hossein Pourgholami